What is the address of DELCARTE UROLOGIE?

The registered office of DELCARTE UROLOGIE is located at Chemin du Fond Coron 29, 1380 Lasne.

Is DELCARTE UROLOGIE still active?

Yes. According to the CBE (30 September 2026) DELCARTE UROLOGIE is active, legal situation “Normale toestand”, started on 27 April 2020.

Is DELCARTE UROLOGIE registered on Peppol?

Yes, DELCARTE UROLOGIE is registered on the Peppol network with ID 0208:0746531103.

What is the enterprise number of DELCARTE UROLOGIE?

The enterprise number of DELCARTE UROLOGIE is BE0746531103.

When was DELCARTE UROLOGIE founded?

DELCARTE UROLOGIE was founded on 27 April 2020.

Who are the directors of DELCARTE UROLOGIE?

According to the 2024 annual accounts, the directors of DELCARTE UROLOGIE are: LESLIE DELCARTE.

Is DELCARTE UROLOGIE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 27 April 2020; 4 annual accounts filed, latest fiscal year 2024; 1 directors known from the annual account.

How much profit did DELCARTE UROLOGIE make in 2024?

DELCARTE UROLOGIE posted a profit after taxes of € 162,464 in financial year 2024.

What is the revenue of DELCARTE UROLOGIE?

As a small company, DELCARTE UROLOGIE is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 215,083.

DELCARTE UROLOGIE (Private Limited) - Lasne

Dossier DELCARTE UROLOGIE, printed on 30 September 2026 from databakkes.be/en/0746531103/delcarte-urologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2024

DELCARTE UROLOGIE from Lasne, company number BE0746531103, closed financial year 2024 with a result of € 162,464 after tax. For that financial year DELCARTE UROLOGIE recorded a gross margin of € 215,083 and equity of € 110,810. Compared with financial year 2023, the result moved from € 147,367 to € 162,464. Profitable, and profit is growing. The buffer shrank hard: equity is 54 % below last year. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2025.

What it is worth Shrank hard

€ 110,810

▼ 54% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 162,464

▲ 10% vs 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 254,200

▼ 17% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 294,141 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2024

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 11,265

▼ 18% vs 2023

Book value of vehicles, furniture and equipment.

Debts at end 2024

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 2,560

▲ 177% vs 2023

Supplier invoices still open on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ 70,258 Gross margin 2021: € 70,258 First fiscal year in the series	€ 72,074 Gross margin 2022: € 72,074 ▲ 3% vs 2021 (€ 70,258) Favourable step	€ 196,850 Gross margin 2023: € 196,850 ▲ 173% vs 2022 (€ 72,074) Favourable step	€ 215,083 Gross margin 2024: € 215,083 ▲ 9% vs 2023 (€ 196,850) Favourable step	▲ 9%
Profit after taxes	€ 55,070 Profit after taxes 2021: € 55,070 First fiscal year in the series	€ 55,285 Profit after taxes 2022: € 55,285 Unchanged (€ 55,070) Favourable step	€ 147,367 Profit after taxes 2023: € 147,367 ▲ 167% vs 2022 (€ 55,285) Favourable step	€ 162,464 Profit after taxes 2024: € 162,464 ▲ 10% vs 2023 (€ 147,367) Favourable step	▲ 10%
Equity	€ 101,014 Equity 2021: € 101,014 First fiscal year in the series	€ 156,298 Equity 2022: € 156,298 ▲ 55% vs 2021 (€ 101,014) Favourable step	€ 242,487 Equity 2023: € 242,487 ▲ 55% vs 2022 (€ 156,298) Favourable step	€ 110,810 Equity 2024: € 110,810 ▼ 54% vs 2023 (€ 242,487) Unfavourable step	▼ 54%
Total debts	€ 19,408 Total debts 2021: € 19,408 First fiscal year in the series	€ 3,958 Total debts 2022: € 3,958 ▼ 80% vs 2021 (€ 19,408) Favourable step	€ 78,511 Total debts 2023: € 78,511 ▲ € 74,553 vs 2022 (€ 3,958) Unfavourable step	€ 159,103 Total debts 2024: € 159,103 ▲ 103% vs 2023 (€ 78,511) Unfavourable step	▲ 103%
Cash	€ 99,660 Cash 2021: € 99,660 First fiscal year in the series	€ 146,920 Cash 2022: € 146,920 ▲ 47% vs 2021 (€ 99,660) Favourable step	€ 307,036 Cash 2023: € 307,036 ▲ 109% vs 2022 (€ 146,920) Favourable step	€ 254,200 Cash 2024: € 254,200 ▼ 17% vs 2023 (€ 307,036) Unfavourable step	▼ 17%
Retained profit	€ 98,514 Retained profit 2021: € 98,514 First fiscal year in the series	€ 153,798 Retained profit 2022: € 153,798 ▲ 56% vs 2021 (€ 98,514) Favourable step	€ 239,987 Retained profit 2023: € 239,987 ▲ 56% vs 2022 (€ 153,798) Favourable step	€ 108,310 Retained profit 2024: € 108,310 ▼ 55% vs 2023 (€ 239,987) Unfavourable step	▼ 55%
Dividend	€ 0 Dividend 2021: € 0 First fiscal year in the series	€ 0 Dividend 2022: € 0 Unchanged (€ 0) Unchanged	€ 61,177 Dividend 2023: € 61,177 Unchanged (€ 0) Unchanged	€ 294,141 Dividend 2024: € 294,141 ▲ € 232,964 vs 2023 (€ 61,177) Unchanged	▲ € 232,964
Balance sheet total	€ 120,422 Balance sheet total 2021: € 120,422 First fiscal year in the series	€ 160,256 Balance sheet total 2022: € 160,256 ▲ 33% vs 2021 (€ 120,422) Unchanged	€ 320,999 Balance sheet total 2023: € 320,999 ▲ 100% vs 2022 (€ 160,256) Unchanged	€ 269,913 Balance sheet total 2024: € 269,913 ▼ 16% vs 2023 (€ 320,999) Unchanged	▼ 16%

Key figures of DELCARTE UROLOGIE, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to DELCARTE UROLOGIE?

What happened at DELCARTE UROLOGIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 30, 2025 New annual accounts for financial year 2024: profit of € 162,464 (▲ 10% vs 2023). Source: NBB ↗
Apr 27, 2020 New establishment in Lasne. KBO
Apr 27, 2020 Start of the company according to the CBE. KBO
2020 LESLIE DELCARTE became a director. NBB

In short

From € 55,070 profit in 2021 to € 162,464 profit in 2024.

Paid € 122,496 in corporate taxes since 2021.

Best year ever: 2024, with € 162,464 profit.

Paid out € 355,319 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DELCARTE UROLOGIE? We notify you, reason included.

Follow DELCARTE UROLOGIE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

LESLIE DELCARTE

DELCARTE UROLOGIE

Urologie Sint Jan Brussel 33.3%

Behind DELCARTE UROLOGIE is LESLIE DELCARTE. It owns 33.3% of Urologie Sint Jan Brussel itself.

See the full network in the app

Directors

According to the 2024 annual accounts

LESLIE DELCARTE

Director

since 2020

Establishments

Establishment units

Physical locations of this company

Registered office

Chemin du Fond Coron 29

1380 Lasne

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0746.531.103
VAT number: BE 0746.531.103
Registered office: Chemin du Fond Coron 29, 1380 Lasne
Names & denominations: DELCARTE UROLOGIE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 27 April 2020
Peppol: Active · Active since 15 Oct 2025

View on CBE Public ↗ Annual accounts (NBB) ↗